Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06925997 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Metabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery

Study acronym: Bile-bar
StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Non-randomized, open-label, parallel-group clinical study evaluating the effects of endogenous bile acids on changes in plasma fibroblast growth factor-19 (FGF-19) and glucose metabolism by extended depletion of circulating bile acids using colesevelam as an experimental tool in subjects operated with gastric by-pass (RYGB).
Trial Details
NCT Number NCT06925997
Lead Sponsor Hvidovre University Hospital
Conditions
(from sponsor)		 Bariatric Surgery Candidate, Bile Acid, Elevated Serum, Glucose Metabolism Disorders
Related terms Glucose Metabolism Disorders
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov